Skip to main content
. 2018 Dec 3;144(3):513–524. doi: 10.1002/ijc.31936

Table 3.

Summary of mosaic rearrangements

Case/control Rearrangement Cytoband1 Chr Start Stop Size (Mb) Clonality Validation
Control Deletion 5q14.1‐q33.1 5 82,926,332 151,852,840 68.93 59% MLPA
Control UPD 20q11.23‐q13.33 20 36,224,534 62,912,463 26.69 17% n.d.
Control Duplication 20q11.21‐q13.13 20 30,691,943 49,777,691 19.09 29% n.d.
Control Deletion 2p24.1‐p23.3 2 23,298,851 25,421,803 2.12 57% n.d.
Case Trisomy 12p13.33‐q24.33 12 0 133,851,895 133.85 15% n.d.
Case UPD 17p13.3‐p11.2 17 6,689 17,344,122 17.34 36% MS
Case UPD 11p15.5‐p15.1 11 198,510 21,002,580 20.80 30% MS
Case Deletion 13q14.2‐q14.3 13 50,394,625 51,461,086 1.07 40% MLPA
Case Deletion 10q22.3‐q23.2 10 81,685,024 89,167,880 7.48 49% MLPA
Case UPD 5q14.3‐q23.1 5 89,863,279 120,267,945 30.40 12% n.d.
Case UPD 9p24.3‐p24.1 9 46,587 5,731,315 5.68 14% n.d.
Case Deletion 1q21.1‐q21.2 1 144,988,936 147,823,776 2.83 28% n.d.
Case Deletion 18p11.21 18 12,033,735 14,920,039 2.89 23% n.d.
1

Cytobands and genomic coordinates according to genome build GRCh37/hg19.

Abbreviations: MLPA, multiplex ligation‐dependent probe amplification analysis; MS, microsatellite analysis; n.d., not determined.